Encyclopedia of Law & Economics - 5880 Pharmaceutical Industry

Clerico, Giuseppe (1994), 'Raccolta e allocazione di sangue: donazione, mercato e intervento pubblico (Gathering and allocation of blood: gift, market and public intervention)', 4 Rassegna giuridica della sanitˆ , 140-152.

Elhauge, Einer Richard (1996), 'The Limited Potential of Medical Technology Assessment', Virginia Law Review .

Hertig, Gerard (1994), 'Imperfect Mutual Recognition for EC Financial Services', 14 International Review of Law and Economics , 177-186.

Kitch, Edmund W. (1973), 'The Patent System and the New Drug Application: An Evaluation of the Incentives for Private Investment in New Drug Research and Marketing', in Landau (ed.), Regulating New Drugs , University of Chicago Center for Policy Study.

Kitch, Edmund W. (1980), 'The Political Economy of Innovation in Drugs and Drug Regulation Reform', in Helms, Robert B. (ed.), The International Supply of Medicines: Implications of U.S. Regulatory Reform , Washington, American Enterprise Institute for Public Policy Research.

Kitch, Edmund W. (1986), 'The Vaccine Dilemma', 2 Issues in Science and Technology , 108 ff.

Kitch, Edmund W. (1988), 'American Law and Preventive Vaccination Programs', in Plotkin, Stanley A. and Mortimer, Edward A. (eds.), Vaccines , Philadelphia, W.B. Saunders Company, 612 ff.

Kitch, Edmund W. and Mortimer, Edward A., Jr. (1994), 'American Law, Preventive Vaccine Programs, and the National Vaccine Injury Compensation Program', in Plotkin, Stanley A. and Mortimer, Edward A. (eds.), Vaccines , Philadelphia, W.B. Saunders Company, 93 ff.

MacKaay, Ejan (1992), 'Penser l'informatique gŽnŽtique en droit quŽbŽcois (Thinking about Genetic Computing in Quebec Law)', in Knoppers, Bartha Maria, Cadiet, Lo•c and Laberge, Claude M. (eds.), La gŽnŽtique humaine: de l'information ˆ l'informatisation [Human Genetics: From Information to Computerization] , MontrŽal et Paris, ThŽmis et LITEC, 25-38.

Mariner, Wendy K. (1985), 'The Potential Impact of Pharmaceutical and Vaccine Litigation', in Baily, Mary Ann and Cikins, Warren I. (eds.), The Effects of Litigation on Health Care Costs , Washington, Brookings Institution, 43-68.

Peltzman, Sam (1973), 'The Benefits and Costs of New Drug Regulation', in Landan, Richard (ed.), Regulating New Drugs , University of Chicago Center for Policy Study.

Peltzman, Sam (1975), Regulation of Pharmaceutical Innovation , Washington, American Enterprise Institute for Public Policy Research, 118 p.

Peltzman, Sam (1975), 'The 1962 Drug Amendments: Reply', Journal of Political Economy .

Peltzman, Sam (1975), 'The Diffusion of Pharmaceutical Innovation', in Helms, Robert B., Drug Development and Marketing , American Enterprise Institute Press.

Peltzman, Sam (1977), 'The Effects of Regulation and New Drugs', in Siegan, Bernard H. (ed.), The Interactions of Economics and the Law , Lexington (MA), Lexington Books.

Peltzman, Sam (1987), 'By Prescription Only', 11(3-4) Regulation , 23-28.

Peltzman, Sam (1987), 'The Health Effects of Mandatory Prescriptions', 30 Journal of Law and Economics , 207-238.

Peltzman, Sam (1987), 'Regulation and Health: The Case of Mandatory Prescriptions and an Extension', March Managerial and Decision Economics .

Peltzman, Sam (1987), 'By Prescription Only', ² Regulation .

Rapp, Richard Tilden and Lloyd, Adam (1994), ''Civilized' Pharmaceutical Price Regulation: Can the U.S. Have It Too?', 17(2) Regulation , 72-82.

Rapp, Richard Tilden and Rozek, Richard P. (1992), 'Parallel Trade in Pharmaceuticals: The Impact on Welfare and Innovation', 7 Journal of Economic Integration , 181-203.

Rubin, Paul H. (1994), 'Are Pharmaceutical Ads Deceptive?', Food and Drug Law Journal , 7-21.

Temin, Peter (1992), 'Realized Benefits from Switching Drugs', 35 Journal of Law and Economics , 351-369.